These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24469287)

  • 1. Rotavirus vaccination: a risk factor for intussusception?
    Oberle D; Jenke AC; von Kries R; Mentzer D; Keller-Stanislawski B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Feb; 57(2):234-41. PubMed ID: 24469287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Background paper to the recommendation for routine rotavirus vaccination of infants in Germany.
    Koch J; Wiese-Posselt M; Remschmidt C; Wichmann O; Bertelsmann H; Garbe E; Hengel H; Meerpohl JJ; Mas Marques A; Oppermann H; Hummers-Pradier E; von Kries R; Mertens T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Jul; 56(7):957-84. PubMed ID: 23807405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011.
    Adlhoch C; Hoehne M; Littmann M; Marques AM; Lerche A; Dehnert M; Eckmanns T; Wichmann O; Koch J
    Pediatr Infect Dis J; 2013 Feb; 32(2):e82-9. PubMed ID: 23334342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception.
    Singh T; Delannois F; Haguinet F; Molo LY
    Drug Saf; 2022 Feb; 45(2):155-168. PubMed ID: 35015268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.
    Shui IM; Baggs J; Patel M; Parashar UD; Rett M; Belongia EA; Hambidge SJ; Glanz JM; Klein NP; Weintraub E
    JAMA; 2012 Feb; 307(6):598-604. PubMed ID: 22318281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of rotavirus vaccination in Germany: rotavirus surveillance, hospitalization, side effects and comparison of vaccines.
    Uhlig U; Kostev K; Schuster V; Koletzko S; Uhlig HH
    Pediatr Infect Dis J; 2014 Nov; 33(11):e299-304. PubMed ID: 24911897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between rotavirus vaccination and intussusception in Australian children: A record linkage study.
    Fathima P; Moore HC; Blyth CC; Snelling TL
    Paediatr Perinat Epidemiol; 2020 Sep; 34(5):583-589. PubMed ID: 32163193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the potential risks and benefits of infant rotavirus vaccination in England.
    Clark A; Jit M; Andrews N; Atchison C; Edmunds WJ; Sanderson C
    Vaccine; 2014 Jun; 32(29):3604-10. PubMed ID: 24814524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.
    Desai R; Parashar UD; Lopman B; de Oliveira LH; Clark AD; Sanderson CF; Tate JE; Matus CR; Andrus JK; Patel MM
    Clin Infect Dis; 2012 May; 54(10):1397-405. PubMed ID: 22431803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Society for Paediatric Infectious Diseases consensus recommendations for rotavirus vaccination in Europe: update 2014.
    Vesikari T; Van Damme P; Giaquinto C; Dagan R; Guarino A; Szajewska H; Usonis V
    Pediatr Infect Dis J; 2015 Jun; 34(6):635-43. PubMed ID: 25860532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach.
    Weidemann F; Dehnert M; Koch J; Wichmann O; Höhle M
    Vaccine; 2014 Sep; 32(40):5250-7. PubMed ID: 25045820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intussusception and Monovalent Rotavirus Vaccination in Singapore: Self-Controlled Case Series and Risk-Benefit Study.
    Yung CF; Chan SP; Soh S; Tan A; Thoon KC
    J Pediatr; 2015 Jul; 167(1):163-8.e1. PubMed ID: 25882872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of childhood rotavirus vaccination in Germany.
    Aidelsburger P; Grabein K; Böhm K; Dietl M; Wasem J; Koch J; Ultsch B; Weidemann F; Wichmann O
    Vaccine; 2014 Apr; 32(17):1964-74. PubMed ID: 24561052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants.
    Chang WC; Yen C; Wu FT; Huang YC; Lin JS; Huang FC; Yu HT; Chi CL; Lin HY; Tate JE; Parashar UD; Wu HS; Hsiung CA
    Pediatr Infect Dis J; 2014 Mar; 33(3):e81-6. PubMed ID: 24569388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intussusception following rotavirus vaccination in the Valencia Region, Spain.
    Pérez-Vilar S; Díez-Domingo J; Puig-Barberà J; Gil-Prieto R; Romio S
    Hum Vaccin Immunother; 2015; 11(7):1848-52. PubMed ID: 26083707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intussusception risk after RotaTeq vaccination: evaluation from worldwide spontaneous reporting data using a self-controlled case series approach.
    Escolano S; Hill C; Tubert-Bitter P
    Vaccine; 2015 Feb; 33(8):1017-20. PubMed ID: 25596460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception.
    Patel MM; Clark AD; Glass RI; Greenberg H; Tate J; Santosham M; Sanderson CF; Steele D; Cortese M; Parashar UD
    Vaccine; 2009 May; 27(22):2916-22. PubMed ID: 19428901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotavirus infection and intussusception in Tunisian children: implications for use of attenuated rotavirus vaccines.
    Chouikha A; Fodha I; Maazoun K; Ben Brahim M; Hidouri S; Nouri A; Trabelsi A; Steele AD
    J Pediatr Surg; 2009 Nov; 44(11):2133-8. PubMed ID: 19944222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the introduction of universal rotavirus vaccination in the Netherlands.
    Zomer TP; van Duynhoven YT; Mangen MJ; van der Maas NA; Vennema H; Boot H; de Melker HE
    Vaccine; 2008 Jul; 26(29-30):3757-64. PubMed ID: 18514975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling Analysis.
    Ledent E; Arlegui H; Buyse H; Basile P; Karkada N; Praet N; Nachbaur G
    BioDrugs; 2018 Apr; 32(2):139-152. PubMed ID: 29589230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.